EMAIL THIS PAGE TO A FRIEND

Journal of biomaterials applications

Cell membrane-mimicking coating for blood-contacting polyurethanes.


PMID 25234122

Abstract

The aim of the present work was to develop simple modification technique for polyurethanes (PUs) intended for use in blood-contacting implants (vascular grafts, heart prosthesis, ventricular assist devices). PU surface was modified with soybean-derived phosphatidylcholine (PC) via one-step dip coating technique. In order to evaluate blood compatibility of the obtained materials, samples were contacted with human blood under static and arterial flow-simulated conditions. The PC-modified surfaces were thoroughly characterized and tested for fibrinogen resistance, the ability to resist platelet adhesion and activation, hemolysis percentage and plasma recalcification time. Results demonstrated significant, more than three-fold reduction in the amount of fibrinogen adsorbed to PC-modified materials as compared to non-modified PU. Analysis of the samples' surface after incubation with blood showed high reduction in platelet adhesion. The results were confirmed by analysis of blood samples collected after shear-stress tests--the percentage of free (non-aggregated) platelets remaining in blood samples contacted with PC-coated materials exceeded 70%. The same parameter measured for non-modified PU was significantly lower and equaled 28%.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

29135
Cyclohexanone, Selectophore, ≥99.5%
C6H10O
02482
Cyclohexanone, analytical standard
C6H10O
398241
Cyclohexanone, ACS reagent, ≥99.0%
C6H10O
29140
Cyclohexanone, puriss. p.a., ≥99.5% (GC)
C6H10O
C102180
Cyclohexanone, ReagentPlus®, 99.8%
C6H10O
W390909
Cyclohexanone, 99.8%
C6H10O
49825
DMACA Reagent, for microbiology
C11H13NO
ARK2190
N,N-Dimethylacetamide, PharmaGrade, Manufactured under appropriate GMP controls for pharma and biopharmaceutical production., Ph Eur
C4H9NO
72336
N,N-Dimethylacetamide, analytical standard
C4H9NO
270555
N,N-Dimethylacetamide, for HPLC, ≥99.9%
C4H9NO
38840
N,N-Dimethylacetamide, puriss. p.a., ≥99.5% (GC)
C4H9NO
271012
N,N-Dimethylacetamide, anhydrous, 99.8%
C4H9NO
154806
N,N-Dimethylacetamide, spectrophotometric grade, ≥99%
C4H9NO
17308
N,N-Dimethylacetamide, for peptide synthesis, ≥99.8% (GC)
C4H9NO
D137510
N,N-Dimethylacetamide, ReagentPlus®, 99%
C4H9NO
07-4072
N,N-Dimethylacetamide, SAJ first grade, ≥99.0%
C4H9NO
07-4071
N,N-Dimethylacetamide, SAJ special grade
C4H9NO
185884
N,N-Dimethylacetamide, ReagentPlus®, ≥99%
C4H9NO
D5511
N,N-Dimethylacetamide, ≥99%
C4H9NO
522414
N,N-Dimethylacetamide-d9, 99 atom % D
C4D9NO
78410
o-Phenylenediamine, suitable for fluorescence, ≥99.0% (NT)
C6H8N2
P6662
o-Phenylenediamine dihydrochloride, tablet, 1 mg substrate per tablet
C6H8N2 · 2HCl
P6787
o-Phenylenediamine dihydrochloride, tablet, 2 mg substrate per tablet
C6H8N2 · 2HCl
P8806
o-Phenylenediamine dihydrochloride, tablet, 3 mg substrate per tablet
C6H8N2 · 2HCl
P8787
o-Phenylenediamine dihydrochloride, tablet, 4 mg substrate per tablet
C6H8N2 · 2HCl
P3804
o-Phenylenediamine dihydrochloride, tablet, 5 mg substrate per tablet
C6H8N2 · 2HCl
P6912
o-Phenylenediamine dihydrochloride, tablet, 5 mg substrate per tablet
C6H8N2 · 2HCl
P8287
o-Phenylenediamine dihydrochloride, tablet, 10 mg substrate per tablet
C6H8N2 · 2HCl
P4664
o-Phenylenediamine dihydrochloride, tablet, 15 mg substrate per tablet
C6H8N2 · 2HCl
P7288
o-Phenylenediamine dihydrochloride, tablet, 20 mg substrate per tablet
C6H8N2 · 2HCl